Objective: To review the evidence surrounding Sacral
Neuromodulation therapy and delineate areas that will need more research. Methods:
An extensive search was performed on the available literature on SNM for
lower urinary tract dysfunction. Based on the results of the search, the mechanisms
of action, indications, technique, and patient characteristics of therapy
failures and success are presented and discussed. Results: SNM is accepted by
the FDA since 1997 for the treatment of lower urinary tract dysfunction. As
it is a relatively new procedure, there are variations in the technique of lead
placement, generator choice, testing interval, patient selection, time to
explantation, and definitions of therapy failures and successes. Conclusions:
SNM is a safe and therapeutic option for the treatment of urgencyfrequency
syndrome, urge incontinence, and idiopathic urinary retention. However, there
are multiple unanswered questions that require extensive research.
Cite this paper
Alemi, G. and Dandolu, V. (2013) Sacral neuromodulation therapy of the lower urinary tract: A review of the literature and unanswered questions. Open Journal of Obstetrics and Gynecology, 3, 1-6. doi: 10.4236/ojog.2013.34A001.
 Spinelli, M. (2008) Latest technologic and surgical developments in using InterStim therapy for sacral neuromodulation: Impact on treatment success and safety. European Urology, 54, 1287-1296.
 Amoroso, L., Pelliccioni, G., Ghiselli, R., et al. (2005) Sacral-neuromodulation CT-guided. La Radiologia Medica, 9, 421-429.
 Govaert, B. (2009) Can sensory and/or motor reactions during percutaneous nerve evaluation predict outcome of sacral nerve modulation? Diseases of the Colon & Rectum, 52, 1423-1426.
 Vasdev N. (2010) The surgical management of the refractory overactive bladder. Indian Journal of Urology, 26, 263-269. doi:10.4103/0970-1591.65402
 Janknegt, R.A., Weil, E.H. and Eerdmans, P.H. (1997) Improving neuromodulation technique for refractory voiding dysfunctions: Two stage implant. Urology, 49, 358-362. doi:10.1016/S0090-4295(96)00506-7
 Everaert, K., Kerckhaert, W., Caluwaerts, H., et al. (2004) A prospective randomized trial comparing the 1-stage with the 2-stage implantation of a pulse generator in patients with pelvic floor dysfunction selected for sacral nerve stimulation. European Urology, 45, 649-654.
 Bannowsky, A., Wefer, B., Braun, P., et al. (2008) Urodynamic changes and response rates in patients treated with permanent electrodes compared to conventional wire electrodes in the peripheral nerve evaluation test. World Journal of Urology, 26, 623-626.
 Borawski, K., Foster, R., Webster, G., et al. (2007) Predicting implantation with a neuromodulator using two different test stimulation techniques: A prospective randomized study in urge incontinent women. Neurourology and Urodynamics, 26, 14-18. doi:10.1002/nau.20332
 Spinelli, M. and Sievert, K.D. (2008) Latest technologic and surgical developments in using InterStim therapy for sacral neuromodulation: impact on treatment success and safety. European Urology, 54, 1287-1296.
 Peters, K.M., Carey, J.M. and Konstandt, D.B. (2003) Sacral neuromodulation for the treatment of refractory interstitial cystitis: Outcomes based on technique. International Urogynecology Journal, 14, 223-228.
 Hauck, E.F., Schwefer, M., Wittkowski, W. and Bothe, H.W. (2009) Measurements and mapping of 282,420 nerve fibers in the S1-5 nerve roots. Journal of Neurosurgery: Spine, 11, 255-263.
 Sutherland, S.E., Lavers, A., Carlson, A., et al. (2007) Sacral nerve stimulation for voiding dysfunction: One institution’s 11-year experience. Neurourology and Urodynamics, 26, 19-28. doi:10.1002/nau.20345
 Baxter, C. and Kim, J. (2010) Contrasting the percutaneous nerve evaluation versus staged implantation in sacral neuromodulation. Current Urology Reports, 11, 310-314.
 Nikolavsky, D., Killinger, K., Boura, J. and Peters, K. (2011) Comparison of patients undergoing a two stage sacral nerve stimulation procedure: Is there a cost benefit for a single-stage procedure? International Urology and Nephrology, 43, 997-1002.
 Sheepens, W.A., De Bie, R.A., Weil, E.H. and Van Kerrebroeck, P.E. (2002) Unilateral versus bilateral sacral neuromodulation in patients with chronic voiding dysfunction. The Journal of Urology, 168, 2046-2050.
 Marcelissen, T.A., Leong, R.K., Serroyen, J., et al. (2011) The use of bilateral sacral nerve stimulation in patients with loss of unilateral treatment efficacy. The Journal of Urology, 185, 976-980. doi:10.1016/j.juro.2010.10.065
 Amend, B., Khalil, M., Kessler, T.M. and Sievert, K.D. (2011) How does sacral modulation work best? Placement and programming techniques to maximize efficacy. Current Urology Reports, 12, 327-335.
 Amundsen, C., Romero, A.A., Jaminson, M.G. and Webster, G.D. (2005) Sacral neuromodulation for intractable urge incontinence: are there factors associated with a cure? Urology, 66, 746-750. doi:10.1016/j.urology.2005.04.031
 Wallace, P.A., Lane, F.L. and Noblett, K.L. (2007) Sacral nerve neuromodulation in patients with underlying neurologic disease. American Journal of Obstetrics & Gynecology, 197, 96.e1-e5.
 White, W.M., Mobley, J.D., Doggweiler, R., DobmeyerDittrich, C. and Klein, F.A. (2009) Incidence and predictors of complications with sacral neuromodulation. Urology, 73, 731-735.
 Van Kerrebroeck, P.E., Van Voskuilen, A.C., Heesakkers, J.P., et al. (2007) Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. Journal of Urology, 178, 2029-2034. doi:10.1016/j.juro.2007.07.032
 Datta, S.N., Chaliha, C., Singh, A., et al. (2008) Sacral neurostimulation for urinary retention: 10-year experience from one UK Centre. BJU International, 101, 192-196.
 Nold, C.J. and McLennan, M.T. (2007) Spontaneous extrusion of sacral nerve implant secondary to massive weight loss. International Urogynecology Journal and Pelvic Floor Dysfunction, 18, 105-107.
 Levin, P.J., Wu, J.M., Siddiqui, N.Y. and Amundsen, C.L. (2012) Does obesity impact the success of an InterStim test phase for the treatment of refractory urge urinary incontinence in female patients? Female Pelvic Medicine & Reconstructive Surgery, 18, 243-246.
 Cohen, B.I. (2006) Predictors of success for first stage neuromodulation: Motor versus sensory response. Journal of Urology, 175, 2178-2180.
 Peters, K. (2011) Is sensory testing during lead placement crucial for achieving positive outcomes after sacral neuromodulation? Neurourology and Urodynamics, 30, 1489-1492. doi:10.1002/n au.21122
 Siegel, S.W., Catanzaro, F., Dijkema, H.E., et al. (2000) Long term results of a multicenter study on sacral nerve stimulation for treatment of urinary urge incontinence, urgency-frequency, and retention. Urology, 56, 87-91.
 Siddiqui, N.Y., Wu, J.M. and Amundsen, C.L. (2010) Overactive bladder: A systematic review. Neuro and Urod. 29:S18-23. doi:10.1002/nau.20786
 Yazdany, T., Bhatia, N. and Nguyen, J. (2011) Determining outcomes, adverse events, and predictors of success after sacral neuromodulation for lower urinary disorders in women. International Urogynecology Journal, 22, 1549-1554. doi:10.1007/s00192-011-1512-2
 Aboseif, S., Tamaddon, K., Chalfin, S., Freedman, S. and Kaptein, J. (2002) Sacral neuromodulation as an effective treatment for refractory pelvic floor dysfunction. Urology, 60, 52-56. doi:10.1016/S0090-4295(02)01630-8